Global Active Pharmaceutical Ingredients (API) Market · GlobeNewswire Inc. Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients (API) - Global Strategic Business Report" ...

BOCA RATON, Fla.-- (BUSINESS WIRE)--March 19, 2026-- ...

QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...

Pune, July 05, 2024 (GLOBE NEWSWIRE) -- Active Pharmaceutical Ingredient Market Analysis: “According to SNS Insider Research, The Active Pharmaceutical Ingredient Market is valued at USD 239.45 ...

India’s Torrent Pharma, which has been beefing up its international focused production capabilities, is buying an API operation from another Indian player. The Ahmedabad-based drugmaker today reported ...

The Active Pharmaceutical Ingredient (API) Market report delivers crucial insights into the market's growth trajectory and the primary revenue drivers anticipated between 2025 and 2034. As industries ...

The Active Pharmaceutical Ingredients (API) Market plays a crucial role in the pharmaceutical industry, forming the backbone of drug development and production. APIs are the biologically active ...

Ajinomoto Bio-Pharma Services is taking full control of an API manufacturing facility in India as the CDMO continues to bulk up in a market that favors companies that can do it all. Ajinomoto ...

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...

Pakistan's pharmaceutical industry, valued at Rs. 748 billion, faces challenges with API imports. Localizing API production ...

MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients. Following the MHRA decision, pharma& expects that ...